BetterLife (BETRF) Pharma is issuing the a press release in response to British Columbia Securities Commission’s May 21, 2025 news release. BetterLife announced on July 16, 2024, that it had amended its past Management Information Circulars to correct disclosures of beneficial ownership by its CEO Ahmad Doroudian. Since early 2023, through direct investment of $675,000 and settlement of his annual salary with BetterLife shares, Dr. Doroudian has increased his ownership from approximately 5.8 million shares to 16 million shares. “I am disappointed by the recent BCSC penalty, but extremely proud of my contributions to BetterLife and the Company’s achievements thus far. I am truly excited about the prospects of BetterLife and its lead asset BETR-001,” said Dr. Doroudian.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BETRF:
- Psychedelic: Atai, Enveric, Incannex and Relmada report quarterly results
- BetterLife Pharma Advances BETR-001 for Psychiatric Treatment
- BetterLife provides update of mechanism of action of BETR-001
- BetterLife Pharma Settles Debts with Share Issuance
- BetterLife Pharma Strengthens Leadership with New Corporate Advisor